| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |